Could kidney glomerular filtration impairment represent the "Achilles heel" of HE4 serum marker? A possible further implication

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 3, 2014, Pages

  Gizzo, Salvatore ^a   Ancona, Emanuele ^b   Saccardi, Carlo ^b   D'Antona, Donato ^b   Nardelli, Giovanni Battista ^b   Plebani, Mario ^b  

^a Azienda Ospedaliero Universitaria   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bias; Biomarkers; He4 serum level; Ovarian cancer markers; Renal failure; Serum dosage

Indexed keywords

CA 125 ANTIGEN; HUMAN EPIDIDYMIS PROTEIN 4;

CANCER PROGNOSIS; CANCER STAGING; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; LETTER; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; QUANTITATIVE ASSAY; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; PROTEINS;

EID: 84896129164     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0660     Document Type: Letter

References (9)

1. Plebani M; HE4 Study Group. HE4 in gynecological cancers: report of a European investigators and experts meeting. Clin Chem Lab Med 2012;50:2127-36.
2. Sandri MT, Bottari F, Franchi D, Boveri S, Candiani M, Ronzoni S, et al. Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome. Gynecol Oncol 2013;128:233-8.
3. Bolstad N, Øijordsbakken M, Nustad K, Bjerner J. Human epididymis protein 4 reference limits and natural variation in a Nordic reference population. Tumour Biol 2012;33:141-8.
4. Moore RG, Miller MC, Eklund EE, Lu KH, Bast RC Jr., Lambert-Messerlian G. Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age. Am J Obstet Gynecol 2012;206:349.e1-7.
5. Escudero JM, Auge JM, Filella X, Torne A, Pahisa J, Molina R. Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases. Clin Chem 2011;57:1534-44.
6. Hertlein L, Stieber P, Kirschenhofer A, Krocker K, Nagel D, Lenhard M, et al. Human epididymis protein 4 (HE4) in benign and malignant diseases. Clin Chem Lab Med 2012;50:2181-8.
7. Nagy B Jr., Krasznai ZT, Balla H, Csobán M, Antal-Szalmás P, Hernádi Z, et al. Elevated human epididymis protein 4 concentrations in chronic kidney disease. Ann Clin Biochem 2012;49:377-80.
8. Hellstrom I, Heagerty PJ, Swisher EM, Liu P, Jaffar J, Agnew K, et al. Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms. Cancer Lett 2010;296:43-8.
9. Macuks R, Baidekalna I, Donina S. Urinary concentrations of human epidydimis secretory protein 4 (He4) in the diagnosis of ovarian cancer: a case-control study. Asian Pac J Cancer Prev 2012;13:4695-8.